Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
21
NMPA:21
Drug Approvals
Lansoprazole for Injection
- Product Name
- 注射用兰索拉唑
- Approval Number
- 国药准字H20140047
- Approval Date
- Oct 25, 2023
NMPA
Ganciclovir for Injection
- Product Name
- 注射用更昔洛韦
- Approval Number
- 国药准字H20084109
- Approval Date
- May 5, 2023
NMPA
Pantoprazole Sodium for lnjection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20083929
- Approval Date
- May 5, 2023
NMPA
Ganciclovir for Injection
- Product Name
- 注射用更昔洛韦
- Approval Number
- 国药准字H20084108
- Approval Date
- May 5, 2023
NMPA
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20083725
- Approval Date
- Feb 5, 2023
NMPA
Omeprazole Sodium for Injection
- Product Name
- 注射用奥美拉唑钠
- Approval Number
- 国药准字H20073768
- Approval Date
- Mar 8, 2022
NMPA
Pentoxifylline for Injection
- Product Name
- 注射用己酮可可碱
- Approval Number
- 国药准字H20040767
- Approval Date
- Jul 23, 2020
NMPA
Human Interleukin-2 for Injection
- Product Name
- 因特康
- Approval Number
- 国药准字S10970054
- Approval Date
- Jul 23, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found